ramosetron with saline
DrugGroup A : saline 1 ml, ramosetron 6μg/kg
NCT Number: NCT01013012
The purpose of this study is to study the efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Phase 4
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group A : saline 1 ml, ramosetron 6μg/kg
Group B : dexamethasone 4 mg, ramosetron 6μg/kg
Time frame: After spinal surgery
incidence of overall postoperative nausea and vomiting (PONV) between combination of ramosetron and dexamethasone and ramosetron alone in highly susceptible patients
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02466984
Nausea, Pathological Conditions, Signs and Symptoms
Bordeaux, Aquitaine, France
View Trial DetailsNCT01440465
Cancer, Nausea
Avranches, France
View Trial DetailsNCT06439121
Nausea, Nausea, Postoperative
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT07051616
Anxiety, Anxiety Disorders
Selçuklu, Akademi Mahallesi, Turkey (Türkiye)
View Trial Details